dnabw: the income statement

MyFinsight

For the quarter ending 2025-09-30, DNABW made $38,837K in revenue. -$80,412K in net income. Net profit margin of -207.05%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30
Total revenue	38,837
Cost of biosecurity revenue-Biosecurity	8,177
Cost of biosecurity revenue-Other Revenue	4,625
Research and development	69,353
General and administrative	44,954
Goodwill impairment	0
Restructuring charges	1,745
Total operating expenses	128,854
Loss from operations	-90,017
Interest income, net	5,742
Gain (loss) on investments	3,684
Loss on deconsolidation of subsidiary	0
Change in fair value of warrant liabilities	0
Other income (expense), net	-163
Total other income (expense)	9,263
Loss before income taxes	-80,754
Income tax (benefit) expense	1
Net loss	-80,755
Foreign currency translation adjustment	27
Reclassification of foreign currency translation adjustment realized upon sale of foreign subsidiary	0
Unrealized gains (loss) on available-for-sale securities	316
Total other comprehensive (loss) income	343
Comprehensive loss	-80,412

Basic (in shares)	55,633,718
Diluted (in shares)	55,633,718
Net loss per share, basic (in dollars per share)	-1.45
Net loss per share, diluted (in dollars per share)	-1.45